Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Go Back to All Clinical Trials

Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Brief description of study

If you have been diagnosed with non-smail cell lung cancer (NSCLC), you may qualify for this study evaluating the usefulness of the brachytherapy source - CivaSheet®. The main goal of this study is to evaluate the usefulness of a brachytherapy device (the insertion of radioactive implants into the tissue) which is designed to deliver the radiation source targeted directly to the tumor.

Clinical Study Identifier: s17-01418

ClinicalTrials.gov Identifier: NCT03290534

Principal Investigator: Michael Zervos.

Other Investigators: Harvey I Pass, Beverly E Smith, Costas Bizekis, Robert J. Cerfolio, Benjamin Cooper.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies